Market Overview of the Global Food Allergy Market

The Food Allergy Market size is expected to grow from USD 38 Billion in 2022 to USD 56.14 Billion by 2030, at a CAGR of 5.00% during the forecast period.

Food allergy can be explained as an immune system reaction to a certain kind of food. Eating even small amount of the allergy-causing food may trigger signs and symptoms in the person. Such symptoms include digestive problems, hives, vomiting, whizzing or swollen airways. In some cases, a food allergy can also cause severe symptoms or even a life-threatening reaction known as anaphylaxis, a very fatal whole-body allergic reaction that can limit breathing, produce a significant decrease in blood pressure, and affect the heart rate. It is recorded that food allergy affects around 8% of children under age 5 and up to 4% of adults. Food allergy symptoms are more frequently seen in infants and children, but there are chances that they can occur at any age and even to the individuals even acquire a food allergy that they have consumed without no problem for many years.

People are allergic to more than 160 ingredients in food but the most common of them are milk, eggs, wheat, shellfish & fish, peanuts, tree nuts, soybeans and sesame. The source behind the allergy can be diagnosed but the diagnosis is based on the patient’s history and physical exam. However, food allergy testing is performed firsthand to determine whether an adult or child is allergic to a certain food or not. The most common Food Allergy diagnosis methods are Skin Prick Tests (SPT), double-blind placebo-controlled food challenge (DBPCFC), Atopy Patch Test (APT), vitro diagnostics and several other methods. The increasing incidence of food allergies and related issues is raising food safety and public health concerns which is estimated to lead to increase in demand of diagnostic techniques and further treatments and medications.

Market Dynamics and Factors of the Global Food Allergy Market

Drivers:

• Increasing Level of Innovation in Allergy Testing and Treatment Processes Along with Rising Expenditure on Healthcare

Restraints:

• High Costs Associated with The Treatment of Allergies and Other Symptoms and Lack of Good Healthcare Infrastructure and Skilled Professionals

Opportunities:

• Ever Rising Food Allergy Cases Even in The Adults and Fully Operational R&D Activities Ongoing in Healthcare to Tackle Them

Regional Analysis Of Food Allergy Market

North America serves as a large base for food allergy cases in the entire world, where the number of these cases is steadily increasing because of this reason North America dominates the food allergy market. Rising food allergies in the region are leading to more need for treatment technologies and medications for instance, FAAN estimate based on phone surveys, found that about 4% of the US population about 12 million people are allergic to peanuts, tree nuts, fish or shellfish. But, this number is even higher and is growing at a significant rate. In addition to all this, rising healthcare expenditure in the countries residing in North America is been proving beneficial for the growth of overall Food Allergy Market in the region.

Most of the key players of Food Allergy Market have their operational presence in North America which is estimated to further propel the market's growth. All the factors such as, Rising Food Allergy Cases, Rising Healthcare Expenditure, Better Healthcare Infrastructure and skilled medical professionals in the region are going to boost the market growth during the forecast period in North America.

COVID-19 Impact on the Global Food Allergy Market

COVID-19 is a global pandemic that has negatively impacted the entire world and also our entire economy. World Health Organization (WHO) declared COVID-19 as a global emergency forcing the healthcare sector to be rigorous and strong in its operations. But, during the initial phase of pandemic in 2020 the heavy lockdowns and other strict regulations imposed by the authorities led to frequent halts even in the medical supplies. Various measures to prevent the disease's spread were recommended due to which other medical issues such as food allergy treatments were neglected. All the specialty clinics and other healthcare houses were turned into COVID care hospitals in order to accommodate the rising number of patients of COVID-19 due to which there was no post for the Food Allergy treatments and its related medical assistance.

Moreover, the healthcare organizations in different countries faced difficulties in continuing their supply chain and distribution activities. Other than that, several researches conducted regarding Food Allergy and COVID-19 during pandemic period indicated lesser Food Allergy Cases. For instance, a study conducted by National Institutes of Health found that people with food allergies are less likely to become infected with SARS-CoV-2, the virus that causes COVID-19, than people without them, due to which there was less demand for food allergy treatments and other associated devices.

Top Key Players Covered Global Food Allergy Market

• Boehringer Ingelheim International GmbH (Germany)
• Aimmune Therapeutics, Inc(USA)
• Johnson & Johnson Private Limited (USA)
• Merck & Co., Inc (USA)
• Prestige Consumer Healthcare Inc (USA)
• Bayer AG (Germany)
• AstraZeneca (UK)
• DBV Technologies (France)
• Novartis Pharmaceuticals (Switzerland)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Alladapt Immunotherapeutics (USA)
• Vedanta Biosciences, Inc (USA)
• Alladapt Immunotherapeutics (USA)
• Almirall, S.A (Spain)
• Sanofi (France)
• Pfizer Inc (USA) and Other Key Players.

Key Industry Developments in the Global Food Allergy Market

In May 2022, Amulet, the company making the world’s smallest, fastest, and sleekest molecular detection technologies announced its official launch “Allergy Amulet”. Amulet’s new launch Allergy Amulet is an innovation in food allergy, a signature wearable that alerts people to allergens in their food.

In October 2020, PALFORZIA, was developed and launched by Aimmune Therapeutics Inc., a Nestlé Health Science company. PALFORZIA® is the first FDA-approved food allergy treatment. PALFORZIA was approved as oral immunotherapy (OIT) on January 31, 2020, by the FDA for the mitigation of allergic reactions, including anaphylaxis. This food allergy drug received the approval from the European Commission (EC) in December 2020, whereas in April 2021, by the Medicines and Healthcare products Regulatory Agency (MHRA) (U.K.).

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Food Source
 3.2 By Symptoms
 3.3 By Treatment
 3.4 By End User
 3.5 By Distribution Channel

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Food Allergy Market by Food Source
 5.1 Food Allergy Market Overview Snapshot and Growth Engine
 5.2 Food Allergy Market Overview
 5.3 Crustacean shellfish
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Crustacean shellfish: Geographic Segmentation
 5.4 Dairy Products
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Dairy Products: Geographic Segmentation
 5.5 Poultry Products
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Poultry Products: Geographic Segmentation
 5.6 Wheat
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Wheat: Geographic Segmentation
 5.7 Soybeans
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size (2016-2028F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Soybeans: Geographic Segmentation
 5.8 Tree Nuts
  5.8.1 Introduction and Market Overview
  5.8.2 Historic and Forecasted Market Size (2016-2028F)
  5.8.3 Key Market Trends, Growth Factors and Opportunities
  5.8.4 Tree Nuts: Geographic Segmentation
 5.9 Peanuts
  5.9.1 Introduction and Market Overview
  5.9.2 Historic and Forecasted Market Size (2016-2028F)
  5.9.3 Key Market Trends, Growth Factors and Opportunities
  5.9.4 Peanuts: Geographic Segmentation
 5.10 Others
  5.10.1 Introduction and Market Overview
  5.10.2 Historic and Forecasted Market Size (2016-2028F)
  5.10.3 Key Market Trends, Growth Factors and Opportunities
  5.10.4 Others: Geographic Segmentation

Chapter 6: Food Allergy Market by Symptoms
 6.1 Food Allergy Market Overview Snapshot and Growth Engine
 6.2 Food Allergy Market Overview
 6.3 Anaphylaxis
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Anaphylaxis: Geographic Segmentation
 6.4 Hives
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Hives: Geographic Segmentation
 6.5 Atopic Dermatitis
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Atopic Dermatitis: Geographic Segmentation
 6.6 Wheezing
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size (2016-2028F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Wheezing: Geographic Segmentation
 6.7 Others
  6.7.1 Introduction and Market Overview
  6.7.2 Historic and Forecasted Market Size (2016-2028F)
  6.7.3 Key Market Trends, Growth Factors and Opportunities
  6.7.4 Others: Geographic Segmentation

Chapter 7: Food Allergy Market by Treatment
 7.1 Food Allergy Market Overview Snapshot and Growth Engine
 7.2 Food Allergy Market Overview
 7.3 Epinephrine injection
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Epinephrine injection: Geographic Segmentation
 7.4 Oral Immunotherapy (OIT)
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Oral Immunotherapy (OIT): Geographic Segmentation
 7.5 Epicutaneous Immunotherapy (EPIT)
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2016-2028F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Epicutaneous Immunotherapy (EPIT): Geographic Segmentation
 7.6 Antihistamines
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size (2016-2028F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Antihistamines: Geographic Segmentation
 7.7 Others
  7.7.1 Introduction and Market Overview
  7.7.2 Historic and Forecasted Market Size (2016-2028F)
  7.7.3 Key Market Trends, Growth Factors and Opportunities
  7.7.4 Others: Geographic Segmentation

Chapter 8: Food Allergy Market by End User
 8.1 Food Allergy Market Overview Snapshot and Growth Engine
 8.2 Food Allergy Market Overview
 8.3 Hospitals
  8.3.1 Introduction and Market Overview
  8.3.2 Historic and Forecasted Market Size (2016-2028F)
  8.3.3 Key Market Trends, Growth Factors and Opportunities
  8.3.4 Hospitals: Geographic Segmentation
 8.4 Specialty Clinics
  8.4.1 Introduction and Market Overview
  8.4.2 Historic and Forecasted Market Size (2016-2028F)
  8.4.3 Key Market Trends, Growth Factors and Opportunities
  8.4.4 Specialty Clinics: Geographic Segmentation
 8.5 Individuals
  8.5.1 Introduction and Market Overview
  8.5.2 Historic and Forecasted Market Size (2016-2028F)
  8.5.3 Key Market Trends, Growth Factors and Opportunities
  8.5.4 Individuals: Geographic Segmentation
 8.6 Others
  8.6.1 Introduction and Market Overview
  8.6.2 Historic and Forecasted Market Size (2016-2028F)
  8.6.3 Key Market Trends, Growth Factors and Opportunities
  8.6.4 Others: Geographic Segmentation

Chapter 9: Food Allergy Market by Distribution Channel
 9.1 Food Allergy Market Overview Snapshot and Growth Engine
 9.2 Food Allergy Market Overview
 9.3 Hospital Pharmacy
  9.3.1 Introduction and Market Overview
  9.3.2 Historic and Forecasted Market Size (2016-2028F)
  9.3.3 Key Market Trends, Growth Factors and Opportunities
  9.3.4 Hospital Pharmacy: Geographic Segmentation
 9.4 Retail Pharmacy
  9.4.1 Introduction and Market Overview
  9.4.2 Historic and Forecasted Market Size (2016-2028F)
  9.4.3 Key Market Trends, Growth Factors and Opportunities
  9.4.4 Retail Pharmacy: Geographic Segmentation
 9.5 Online Pharmacy
  9.5.1 Introduction and Market Overview
  9.5.2 Historic and Forecasted Market Size (2016-2028F)
  9.5.3 Key Market Trends, Growth Factors and Opportunities
  9.5.4 Online Pharmacy: Geographic Segmentation

Chapter 10: Company Profiles and Competitive Analysis
 10.1 Competitive Landscape
  10.1.1 Competitive Positioning
  10.1.2 Food Allergy Sales and Market Share By Players
  10.1.3 Industry BCG Matrix
  10.1.4 Heat Map Analysis
  10.1.5 Food Allergy Industry Concentration Ratio (CR5 and HHI)
  10.1.6 Top 5 Food Allergy Players Market Share
  10.1.7 Mergers and Acquisitions
  10.1.8 Business Strategies By Top Players
 10.2 BOEHRINGER INGELHEIM INTERNATIONAL GMBH. (GERMANY)
  10.2.1 Company Overview
  10.2.2 Key Executives
  10.2.3 Company Snapshot
  10.2.4 Operating Business Segments
  10.2.5 Product Portfolio
  10.2.6 Business Performance
  10.2.7 Key Strategic Moves and Recent Developments
  10.2.8 SWOT Analysis
 10.3 AIMMUNE THERAPEUTICS INC (USA)
 10.4 JOHNSON & JOHNSON PRIVATE LIMITED (USA)
 10.5 MERCK & CO. INC. (US)
 10.6 PRESTIGE CONSUMER HEALTHCARE INC. (US)
 10.7 BAYER AG (GERMANY)
 10.8 ASTRAZENECA (UK)
 10.9 DBV TECHNOLOGIES (FRANCE)
 10.10 NOVARTIS PHARMACEUTICALS (SWITZERLAND)
 10.11 F. HOFFMANN-LA ROCHE LTD. (SWITZERLAND)
 10.12 ALLADAPT IMMUNOTHERAPEUTICS (USA)
 10.13 VEDANTA BIOSCIENCES INC (USA)
 10.14 ALLADAPT IMMUNOTHERAPEUTICS (USA)
 10.15 ALMIRALL S.A (SPAIN)
 10.16 SANOFI (FRANCE)
 10.17 PFIZER INC (USA)
 10.18 OTHER MAJOR PLAYERS

Chapter 11: Global Food Allergy Market Analysis, Insights and Forecast, 2016-2028
 11.1 Market Overview
 11.2 Historic and Forecasted Market Size By Food Source
  11.2.1 Crustacean shellfish
  11.2.2 Dairy Products
  11.2.3 Poultry Products
  11.2.4 Wheat
  11.2.5 Soybeans
  11.2.6 Tree Nuts
  11.2.7 Peanuts
  11.2.8 Others
 11.3 Historic and Forecasted Market Size By Symptoms
  11.3.1 Anaphylaxis
  11.3.2 Hives
  11.3.3 Atopic Dermatitis
  11.3.4 Wheezing
  11.3.5 Others
 11.4 Historic and Forecasted Market Size By Treatment
  11.4.1 Epinephrine injection
  11.4.2 Oral Immunotherapy (OIT)
  11.4.3 Epicutaneous Immunotherapy (EPIT)
  11.4.4 Antihistamines
  11.4.5 Others
 11.5 Historic and Forecasted Market Size By End User
  11.5.1 Hospitals
  11.5.2 Specialty Clinics
  11.5.3 Individuals
  11.5.4 Others
 11.6 Historic and Forecasted Market Size By Distribution Channel
  11.6.1 Hospital Pharmacy
  11.6.2 Retail Pharmacy
  11.6.3 Online Pharmacy

Chapter 12: North America Food Allergy Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Food Source
  12.4.1 Crustacean shellfish
  12.4.2 Dairy Products
  12.4.3 Poultry Products
  12.4.4 Wheat
  12.4.5 Soybeans
  12.4.6 Tree Nuts
  12.4.7 Peanuts
  12.4.8 Others
 12.5 Historic and Forecasted Market Size By Symptoms
  12.5.1 Anaphylaxis
  12.5.2 Hives
  12.5.3 Atopic Dermatitis
  12.5.4 Wheezing
  12.5.5 Others
 12.6 Historic and Forecasted Market Size By Treatment
  12.6.1 Epinephrine injection
  12.6.2 Oral Immunotherapy (OIT)
  12.6.3 Epicutaneous Immunotherapy (EPIT)
  12.6.4 Antihistamines
  12.6.5 Others
 12.7 Historic and Forecasted Market Size By End User
  12.7.1 Hospitals
  12.7.2 Specialty Clinics
  12.7.3 Individuals
  12.7.4 Others
 12.8 Historic and Forecasted Market Size By Distribution Channel
  12.8.1 Hospital Pharmacy
  12.8.2 Retail Pharmacy
  12.8.3 Online Pharmacy
 12.9 Historic and Forecast Market Size by Country
  12.9.1 U.S.
  12.9.2 Canada
  12.9.3 Mexico

Chapter 13: Europe Food Allergy Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Food Source
  13.4.1 Crustacean shellfish
  13.4.2 Dairy Products
  13.4.3 Poultry Products
  13.4.4 Wheat
  13.4.5 Soybeans
  13.4.6 Tree Nuts
  13.4.7 Peanuts
  13.4.8 Others
 13.5 Historic and Forecasted Market Size By Symptoms
  13.5.1 Anaphylaxis
  13.5.2 Hives
  13.5.3 Atopic Dermatitis
  13.5.4 Wheezing
  13.5.5 Others
 13.6 Historic and Forecasted Market Size By Treatment
  13.6.1 Epinephrine injection
  13.6.2 Oral Immunotherapy (OIT)
  13.6.3 Epicutaneous Immunotherapy (EPIT)
  13.6.4 Antihistamines
  13.6.5 Others
 13.7 Historic and Forecasted Market Size By End User
  13.7.1 Hospitals
  13.7.2 Specialty Clinics
  13.7.3 Individuals
  13.7.4 Others
 13.8 Historic and Forecasted Market Size By Distribution Channel
  13.8.1 Hospital Pharmacy
  13.8.2 Retail Pharmacy
  13.8.3 Online Pharmacy
 13.9 Historic and Forecast Market Size by Country
  13.9.1 Germany
  13.9.2 U.K.
  13.9.3 France
  13.9.4 Italy
  13.9.5 Russia
  13.9.6 Spain
  13.9.7 Rest of Europe

Chapter 14: Asia-Pacific Food Allergy Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Food Source
  14.4.1 Crustacean shellfish
  14.4.2 Dairy Products
  14.4.3 Poultry Products
  14.4.4 Wheat
  14.4.5 Soybeans
  14.4.6 Tree Nuts
  14.4.7 Peanuts
  14.4.8 Others
 14.5 Historic and Forecasted Market Size By Symptoms
  14.5.1 Anaphylaxis
  14.5.2 Hives
  14.5.3 Atopic Dermatitis
  14.5.4 Wheezing
  14.5.5 Others
 14.6 Historic and Forecasted Market Size By Treatment
  14.6.1 Epinephrine injection
  14.6.2 Oral Immunotherapy (OIT)
  14.6.3 Epicutaneous Immunotherapy (EPIT)
  14.6.4 Antihistamines
  14.6.5 Others
 14.7 Historic and Forecasted Market Size By End User
  14.7.1 Hospitals
  14.7.2 Specialty Clinics
  14.7.3 Individuals
  14.7.4 Others
 14.8 Historic and Forecasted Market Size By Distribution Channel
  14.8.1 Hospital Pharmacy
  14.8.2 Retail Pharmacy
  14.8.3 Online Pharmacy
 14.9 Historic and Forecast Market Size by Country
  14.9.1 China
  14.9.2 India
  14.9.3 Japan
  14.9.4 Singapore
  14.9.5 Australia
  14.9.6 New Zealand
  14.9.7 Rest of APAC

Chapter 15: Middle East & Africa Food Allergy Market Analysis, Insights and Forecast, 2016-2028
 15.1 Key Market Trends, Growth Factors and Opportunities
 15.2 Impact of Covid-19
 15.3 Key Players
 15.4 Key Market Trends, Growth Factors and Opportunities
 15.4 Historic and Forecasted Market Size By Food Source
  15.4.1 Crustacean shellfish
  15.4.2 Dairy Products
  15.4.3 Poultry Products
  15.4.4 Wheat
  15.4.5 Soybeans
  15.4.6 Tree Nuts
  15.4.7 Peanuts
  15.4.8 Others
 15.5 Historic and Forecasted Market Size By Symptoms
  15.5.1 Anaphylaxis
  15.5.2 Hives
  15.5.3 Atopic Dermatitis
  15.5.4 Wheezing
  15.5.5 Others
 15.6 Historic and Forecasted Market Size By Treatment
  15.6.1 Epinephrine injection
  15.6.2 Oral Immunotherapy (OIT)
  15.6.3 Epicutaneous Immunotherapy (EPIT)
  15.6.4 Antihistamines
  15.6.5 Others
 15.7 Historic and Forecasted Market Size By End User
  15.7.1 Hospitals
  15.7.2 Specialty Clinics
  15.7.3 Individuals
  15.7.4 Others
 15.8 Historic and Forecasted Market Size By Distribution Channel
  15.8.1 Hospital Pharmacy
  15.8.2 Retail Pharmacy
  15.8.3 Online Pharmacy
 15.9 Historic and Forecast Market Size by Country
  15.9.1 Turkey
  15.9.2 Saudi Arabia
  15.9.3 Iran
  15.9.4 UAE
  15.9.5 Africa
  15.9.6 Rest of MEA

Chapter 16: South America Food Allergy Market Analysis, Insights and Forecast, 2016-2028
 16.1 Key Market Trends, Growth Factors and Opportunities
 16.2 Impact of Covid-19
 16.3 Key Players
 16.4 Key Market Trends, Growth Factors and Opportunities
 16.4 Historic and Forecasted Market Size By Food Source
  16.4.1 Crustacean shellfish
  16.4.2 Dairy Products
  16.4.3 Poultry Products
  16.4.4 Wheat
  16.4.5 Soybeans
  16.4.6 Tree Nuts
  16.4.7 Peanuts
  16.4.8 Others
 16.5 Historic and Forecasted Market Size By Symptoms
  16.5.1 Anaphylaxis
  16.5.2 Hives
  16.5.3 Atopic Dermatitis
  16.5.4 Wheezing
  16.5.5 Others
 16.6 Historic and Forecasted Market Size By Treatment
  16.6.1 Epinephrine injection
  16.6.2 Oral Immunotherapy (OIT)
  16.6.3 Epicutaneous Immunotherapy (EPIT)
  16.6.4 Antihistamines
  16.6.5 Others
 16.7 Historic and Forecasted Market Size By End User
  16.7.1 Hospitals
  16.7.2 Specialty Clinics
  16.7.3 Individuals
  16.7.4 Others
 16.8 Historic and Forecasted Market Size By Distribution Channel
  16.8.1 Hospital Pharmacy
  16.8.2 Retail Pharmacy
  16.8.3 Online Pharmacy
 16.9 Historic and Forecast Market Size by Country
  16.9.1 Brazil
  16.9.2 Argentina
  16.9.3 Rest of SA

Chapter 17 Investment Analysis

Chapter 18 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. FOOD ALLERGY MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. FOOD ALLERGY MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. FOOD ALLERGY MARKET COMPETITIVE RIVALRY
TABLE 005. FOOD ALLERGY MARKET THREAT OF NEW ENTRANTS
TABLE 006. FOOD ALLERGY MARKET THREAT OF SUBSTITUTES
TABLE 007. FOOD ALLERGY MARKET BY FOOD SOURCE
TABLE 008. CRUSTACEAN SHELLFISH MARKET OVERVIEW (2016-2028)
TABLE 009. DAIRY PRODUCTS MARKET OVERVIEW (2016-2028)
TABLE 010. POULTRY PRODUCTS MARKET OVERVIEW (2016-2028)
TABLE 011. WHEAT MARKET OVERVIEW (2016-2028)
TABLE 012. SOYBEANS MARKET OVERVIEW (2016-2028)
TABLE 013. TREE NUTS MARKET OVERVIEW (2016-2028)
TABLE 014. PEANUTS MARKET OVERVIEW (2016-2028)
TABLE 015. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 016. FOOD ALLERGY MARKET BY SYMPTOMS
TABLE 017. ANAPHYLAXIS MARKET OVERVIEW (2016-2028)
TABLE 018. HIVES MARKET OVERVIEW (2016-2028)
TABLE 019. ATOPIC DERMATITIS MARKET OVERVIEW (2016-2028)
TABLE 020. WHEEZING MARKET OVERVIEW (2016-2028)
TABLE 021. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 022. FOOD ALLERGY MARKET BY TREATMENT
TABLE 023. EPINEPHRINE INJECTION MARKET OVERVIEW (2016-2028)
TABLE 024. ORAL IMMUNOTHERAPY (OIT) MARKET OVERVIEW (2016-2028)
TABLE 025. EPICUTANEOUS IMMUNOTHERAPY (EPIT) MARKET OVERVIEW (2016-2028)
TABLE 026. ANTIHISTAMINES MARKET OVERVIEW (2016-2028)
TABLE 027. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 028. FOOD ALLERGY MARKET BY END USER
TABLE 029. HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 030. SPECIALTY CLINICS MARKET OVERVIEW (2016-2028)
TABLE 031. INDIVIDUALS MARKET OVERVIEW (2016-2028)
TABLE 032. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 033. FOOD ALLERGY MARKET BY DISTRIBUTION CHANNEL
TABLE 034. HOSPITAL PHARMACY MARKET OVERVIEW (2016-2028)
TABLE 035. RETAIL PHARMACY MARKET OVERVIEW (2016-2028)
TABLE 036. ONLINE PHARMACY MARKET OVERVIEW (2016-2028)
TABLE 037. NORTH AMERICA FOOD ALLERGY MARKET, BY FOOD SOURCE (2016-2028)
TABLE 038. NORTH AMERICA FOOD ALLERGY MARKET, BY SYMPTOMS (2016-2028)
TABLE 039. NORTH AMERICA FOOD ALLERGY MARKET, BY TREATMENT (2016-2028)
TABLE 040. NORTH AMERICA FOOD ALLERGY MARKET, BY END USER (2016-2028)
TABLE 041. NORTH AMERICA FOOD ALLERGY MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 042. N FOOD ALLERGY MARKET, BY COUNTRY (2016-2028)
TABLE 043. EUROPE FOOD ALLERGY MARKET, BY FOOD SOURCE (2016-2028)
TABLE 044. EUROPE FOOD ALLERGY MARKET, BY SYMPTOMS (2016-2028)
TABLE 045. EUROPE FOOD ALLERGY MARKET, BY TREATMENT (2016-2028)
TABLE 046. EUROPE FOOD ALLERGY MARKET, BY END USER (2016-2028)
TABLE 047. EUROPE FOOD ALLERGY MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 048. FOOD ALLERGY MARKET, BY COUNTRY (2016-2028)
TABLE 049. ASIA PACIFIC FOOD ALLERGY MARKET, BY FOOD SOURCE (2016-2028)
TABLE 050. ASIA PACIFIC FOOD ALLERGY MARKET, BY SYMPTOMS (2016-2028)
TABLE 051. ASIA PACIFIC FOOD ALLERGY MARKET, BY TREATMENT (2016-2028)
TABLE 052. ASIA PACIFIC FOOD ALLERGY MARKET, BY END USER (2016-2028)
TABLE 053. ASIA PACIFIC FOOD ALLERGY MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 054. FOOD ALLERGY MARKET, BY COUNTRY (2016-2028)
TABLE 055. MIDDLE EAST & AFRICA FOOD ALLERGY MARKET, BY FOOD SOURCE (2016-2028)
TABLE 056. MIDDLE EAST & AFRICA FOOD ALLERGY MARKET, BY SYMPTOMS (2016-2028)
TABLE 057. MIDDLE EAST & AFRICA FOOD ALLERGY MARKET, BY TREATMENT (2016-2028)
TABLE 058. MIDDLE EAST & AFRICA FOOD ALLERGY MARKET, BY END USER (2016-2028)
TABLE 059. MIDDLE EAST & AFRICA FOOD ALLERGY MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 060. FOOD ALLERGY MARKET, BY COUNTRY (2016-2028)
TABLE 061. SOUTH AMERICA FOOD ALLERGY MARKET, BY FOOD SOURCE (2016-2028)
TABLE 062. SOUTH AMERICA FOOD ALLERGY MARKET, BY SYMPTOMS (2016-2028)
TABLE 063. SOUTH AMERICA FOOD ALLERGY MARKET, BY TREATMENT (2016-2028)
TABLE 064. SOUTH AMERICA FOOD ALLERGY MARKET, BY END USER (2016-2028)
TABLE 065. SOUTH AMERICA FOOD ALLERGY MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 066. FOOD ALLERGY MARKET, BY COUNTRY (2016-2028)
TABLE 067. BOEHRINGER INGELHEIM INTERNATIONAL GMBH. (GERMANY): SNAPSHOT
TABLE 068. BOEHRINGER INGELHEIM INTERNATIONAL GMBH. (GERMANY): BUSINESS PERFORMANCE
TABLE 069. BOEHRINGER INGELHEIM INTERNATIONAL GMBH. (GERMANY): PRODUCT PORTFOLIO
TABLE 070. BOEHRINGER INGELHEIM INTERNATIONAL GMBH. (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. AIMMUNE THERAPEUTICS INC (USA): SNAPSHOT
TABLE 071. AIMMUNE THERAPEUTICS INC (USA): BUSINESS PERFORMANCE
TABLE 072. AIMMUNE THERAPEUTICS INC (USA): PRODUCT PORTFOLIO
TABLE 073. AIMMUNE THERAPEUTICS INC (USA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 073. JOHNSON & JOHNSON PRIVATE LIMITED (USA): SNAPSHOT
TABLE 074. JOHNSON & JOHNSON PRIVATE LIMITED (USA): BUSINESS PERFORMANCE
TABLE 075. JOHNSON & JOHNSON PRIVATE LIMITED (USA): PRODUCT PORTFOLIO
TABLE 076. JOHNSON & JOHNSON PRIVATE LIMITED (USA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 076. MERCK & CO. INC. (US): SNAPSHOT
TABLE 077. MERCK & CO. INC. (US): BUSINESS PERFORMANCE
TABLE 078. MERCK & CO. INC. (US): PRODUCT PORTFOLIO
TABLE 079. MERCK & CO. INC. (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 079. PRESTIGE CONSUMER HEALTHCARE INC. (US): SNAPSHOT
TABLE 080. PRESTIGE CONSUMER HEALTHCARE INC. (US): BUSINESS PERFORMANCE
TABLE 081. PRESTIGE CONSUMER HEALTHCARE INC. (US): PRODUCT PORTFOLIO
TABLE 082. PRESTIGE CONSUMER HEALTHCARE INC. (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 082. BAYER AG (GERMANY): SNAPSHOT
TABLE 083. BAYER AG (GERMANY): BUSINESS PERFORMANCE
TABLE 084. BAYER AG (GERMANY): PRODUCT PORTFOLIO
TABLE 085. BAYER AG (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 085. ASTRAZENECA (UK): SNAPSHOT
TABLE 086. ASTRAZENECA (UK): BUSINESS PERFORMANCE
TABLE 087. ASTRAZENECA (UK): PRODUCT PORTFOLIO
TABLE 088. ASTRAZENECA (UK): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 088. DBV TECHNOLOGIES (FRANCE): SNAPSHOT
TABLE 089. DBV TECHNOLOGIES (FRANCE): BUSINESS PERFORMANCE
TABLE 090. DBV TECHNOLOGIES (FRANCE): PRODUCT PORTFOLIO
TABLE 091. DBV TECHNOLOGIES (FRANCE): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 091. NOVARTIS PHARMACEUTICALS (SWITZERLAND): SNAPSHOT
TABLE 092. NOVARTIS PHARMACEUTICALS (SWITZERLAND): BUSINESS PERFORMANCE
TABLE 093. NOVARTIS PHARMACEUTICALS (SWITZERLAND): PRODUCT PORTFOLIO
TABLE 094. NOVARTIS PHARMACEUTICALS (SWITZERLAND): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 094. F. HOFFMANN-LA ROCHE LTD. (SWITZERLAND): SNAPSHOT
TABLE 095. F. HOFFMANN-LA ROCHE LTD. (SWITZERLAND): BUSINESS PERFORMANCE
TABLE 096. F. HOFFMANN-LA ROCHE LTD. (SWITZERLAND): PRODUCT PORTFOLIO
TABLE 097. F. HOFFMANN-LA ROCHE LTD. (SWITZERLAND): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 097. ALLADAPT IMMUNOTHERAPEUTICS (USA): SNAPSHOT
TABLE 098. ALLADAPT IMMUNOTHERAPEUTICS (USA): BUSINESS PERFORMANCE
TABLE 099. ALLADAPT IMMUNOTHERAPEUTICS (USA): PRODUCT PORTFOLIO
TABLE 100. ALLADAPT IMMUNOTHERAPEUTICS (USA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100. VEDANTA BIOSCIENCES INC (USA): SNAPSHOT
TABLE 101. VEDANTA BIOSCIENCES INC (USA): BUSINESS PERFORMANCE
TABLE 102. VEDANTA BIOSCIENCES INC (USA): PRODUCT PORTFOLIO
TABLE 103. VEDANTA BIOSCIENCES INC (USA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 103. ALLADAPT IMMUNOTHERAPEUTICS (USA): SNAPSHOT
TABLE 104. ALLADAPT IMMUNOTHERAPEUTICS (USA): BUSINESS PERFORMANCE
TABLE 105. ALLADAPT IMMUNOTHERAPEUTICS (USA): PRODUCT PORTFOLIO
TABLE 106. ALLADAPT IMMUNOTHERAPEUTICS (USA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 106. ALMIRALL S.A (SPAIN): SNAPSHOT
TABLE 107. ALMIRALL S.A (SPAIN): BUSINESS PERFORMANCE
TABLE 108. ALMIRALL S.A (SPAIN): PRODUCT PORTFOLIO
TABLE 109. ALMIRALL S.A (SPAIN): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 109. SANOFI (FRANCE): SNAPSHOT
TABLE 110. SANOFI (FRANCE): BUSINESS PERFORMANCE
TABLE 111. SANOFI (FRANCE): PRODUCT PORTFOLIO
TABLE 112. SANOFI (FRANCE): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 112. PFIZER INC (USA): SNAPSHOT
TABLE 113. PFIZER INC (USA): BUSINESS PERFORMANCE
TABLE 114. PFIZER INC (USA): PRODUCT PORTFOLIO
TABLE 115. PFIZER INC (USA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 115. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 116. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 117. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 118. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. FOOD ALLERGY MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. FOOD ALLERGY MARKET OVERVIEW BY FOOD SOURCE
FIGURE 012. CRUSTACEAN SHELLFISH MARKET OVERVIEW (2016-2028)
FIGURE 013. DAIRY PRODUCTS MARKET OVERVIEW (2016-2028)
FIGURE 014. POULTRY PRODUCTS MARKET OVERVIEW (2016-2028)
FIGURE 015. WHEAT MARKET OVERVIEW (2016-2028)
FIGURE 016. SOYBEANS MARKET OVERVIEW (2016-2028)
FIGURE 017. TREE NUTS MARKET OVERVIEW (2016-2028)
FIGURE 018. PEANUTS MARKET OVERVIEW (2016-2028)
FIGURE 019. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 020. FOOD ALLERGY MARKET OVERVIEW BY SYMPTOMS
FIGURE 021. ANAPHYLAXIS MARKET OVERVIEW (2016-2028)
FIGURE 022. HIVES MARKET OVERVIEW (2016-2028)
FIGURE 023. ATOPIC DERMATITIS MARKET OVERVIEW (2016-2028)
FIGURE 024. WHEEZING MARKET OVERVIEW (2016-2028)
FIGURE 025. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 026. FOOD ALLERGY MARKET OVERVIEW BY TREATMENT
FIGURE 027. EPINEPHRINE INJECTION MARKET OVERVIEW (2016-2028)
FIGURE 028. ORAL IMMUNOTHERAPY (OIT) MARKET OVERVIEW (2016-2028)
FIGURE 029. EPICUTANEOUS IMMUNOTHERAPY (EPIT) MARKET OVERVIEW (2016-2028)
FIGURE 030. ANTIHISTAMINES MARKET OVERVIEW (2016-2028)
FIGURE 031. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 032. FOOD ALLERGY MARKET OVERVIEW BY END USER
FIGURE 033. HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 034. SPECIALTY CLINICS MARKET OVERVIEW (2016-2028)
FIGURE 035. INDIVIDUALS MARKET OVERVIEW (2016-2028)
FIGURE 036. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 037. FOOD ALLERGY MARKET OVERVIEW BY DISTRIBUTION CHANNEL
FIGURE 038. HOSPITAL PHARMACY MARKET OVERVIEW (2016-2028)
FIGURE 039. RETAIL PHARMACY MARKET OVERVIEW (2016-2028)
FIGURE 040. ONLINE PHARMACY MARKET OVERVIEW (2016-2028)
FIGURE 041. NORTH AMERICA FOOD ALLERGY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 042. EUROPE FOOD ALLERGY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 043. ASIA PACIFIC FOOD ALLERGY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 044. MIDDLE EAST & AFRICA FOOD ALLERGY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 045. SOUTH AMERICA FOOD ALLERGY MARKET OVERVIEW BY COUNTRY (2016-2028)